Animal Models of Choroidal Neovascularization: A Systematic Review

被引:25
作者
Fabian-Jessing, Bjorn K. [1 ]
Jakobsen, Thomas Stax [1 ]
Jensen, Emilie Grarup [1 ]
Alsing, Sidsel [1 ]
Hansen, Silja [1 ]
Aagaard, Lars [1 ]
Askou, Anne Louise [2 ]
Bek, Toke [2 ]
Corydon, Thomas J. [1 ,2 ]
机构
[1] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark
[2] Aarhus Univ Hosp, Dept Ophthalmol, Aarhus, Denmark
关键词
animal model; choroidal neovascularization; neovascular age-related macular degeneration; MACULAR DEGENERATION; INTRAVITREAL INJECTION; VISUAL IMPAIRMENT; CARDIAC-ARREST; AGE; RANIBIZUMAB; BEVACIZUMAB; PROGRESSION; SEVERITY; SAFETY;
D O I
10.1167/iovs.63.9.11
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. Animal models of choroidal neovascularization (CNV) are extensively used to characterize the pathophysiology of chorioretinal diseases with CNV formation and to evaluate novel treatment strategies. This systematic review aims to give a detailed overview of contemporary animal models of CNV. METHODS. A systematic search was performed in PubMed and EMBASE from November 20, 2015, to November 20, 2020, for mammalian animal models of CNV. Following inclusion by two investigators, data from the articles were extracted according to a predefined protocol. RESULTS. A total of 380 full articles, representing 409 independent animal models, were included. Mice were by far the most utilized animal (76%) followed by rats and non-human primates. The median age of rodents was 8 weeks but with a wide range. Male animals were used in 44% of the studies, but 32% did not report the sex. CNV was laser induced in 89% of the studies, but only 44% of these reported sufficiently on standard laser parameters. Surprisingly, 28% of the studies did not report a sample size for quantitative CNV evaluation. Less than half of the studies performed quantitative in vivo evaluation, and 73% evaluated CNV quantitatively ex vivo. Both in vivo and ex vivo evaluations were conducted primarily at day 7 and/or day 14. CONCLUSIONS. The laser-induced mouse model is the predominant model for experimental CNV. The widespread use of young, healthy male animals may complicate clinical translation, and inadequate reporting challenges reproducibility. Definition and implementation of standardized methodologic and reporting guidelines are attractive.
引用
收藏
页码:10 / 10
页数:1
相关论文
共 42 条
[1]   The effects of intravitreous bevacizumab on retinal neovascular membrane and normal capillaries in rabbits [J].
Ameri, Hossein ;
Chader, Gerald J. ;
Kim, June-Gone ;
Sadda, SriniVas R. ;
Rao, Narsing A. ;
Humayun, Mark S. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2007, 48 (12) :5708-5715
[2]   Pipeline therapies for neovascular age related macular degeneration [J].
Arepalli, Sruthi ;
Kaiser, Peter K. .
INTERNATIONAL JOURNAL OF RETINA AND VITREOUS, 2021, 7 (01)
[3]   Preclinical challenges for developing long acting intravitreal medicines [J].
Awwad, Sahar ;
Henein, Christin ;
Ibeanu, Nkiruka ;
Khaw, Peng T. ;
Brocchini, Steve .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2020, 153 :130-149
[4]  
Baker M, 2016, NATURE, V533, P452, DOI 10.1038/533452a
[5]   Raise standards for preclinical cancer research [J].
Begley, C. Glenn ;
Ellis, Lee M. .
NATURE, 2012, 483 (7391) :531-533
[6]   Nonresponders to Ranibizumab Anti-VEGF Treatment Are Actually Short-term Responders: A Prospective Spectral-Domain OCT Study [J].
Bontzos, Georgios ;
Bagheri, Saghar ;
Ioanidi, Larissa ;
Kim, Ivana ;
Datseris, Ioannis ;
Gragoudas, Evangelos ;
Kabanarou, Stamatina ;
Miller, Joan ;
Tsilimbaris, Miltiadis ;
Vavvas, Demetrios G. .
OPHTHALMOLOGY RETINA, 2020, 4 (12) :1138-1145
[7]   Phase 2a Randomized Clinical Trial: Safety and Post Hoc Analysis of Subretinal rAAV.sFLT-1 for Wet Age-related Macular Degeneration [J].
Constable, Ian J. ;
Pierce, Cora M. ;
Lai, Chooi-May ;
Magno, Aaron L. ;
Degli-Esposti, Mariapia A. ;
French, Martyn A. ;
McAllister, Ian L. ;
Butler, Steve ;
Barone, Samuel B. ;
Schwartz, Steven D. ;
Blumenkranz, Mark S. ;
Rakoczy, Elizabeth P. .
EBIOMEDICINE, 2016, 14 :168-175
[8]  
Dot C, 2009, MOL VIS, V15, P670
[9]   Gender and estrogen supplementation increases severity of experimental choroidal neovascularization [J].
Espinosa-Heidmann, DG ;
Marin-Castano, ME ;
Pereira-Simon, S ;
Hernandez, EP ;
Elliot, S ;
Cousins, SW .
EXPERIMENTAL EYE RESEARCH, 2005, 80 (03) :413-423
[10]  
Espinosa-Heidmann DG, 2002, INVEST OPHTH VIS SCI, V43, P1567